Coronavirus

Most recent stories in Coronavirus

• 

  FOX Business

  

  7 hours ago

  Curevac sues BioNTech over COVID-19 vaccine's mRNA technology

  FOX Business - Paul Best

  German biopharmaceutical company CureVac sued BioNTech on Tuesday, seeking "fair compensation" for alleged infringement of intellectual property rights related to the mRNA technology that was used to develop Pfizer and BioNTech's COVID-19 vaccine. "The CureVac intellectual property portfolio …

• 

  FOX Business

  

  10 hours ago

  Novavax expects Omicron-targeting vaccine by fourth quarter

  FOX Business - Julia Musto

  Vaccine-maker Novavax said it expects to be in a position to provide an Omicron-containing vaccine in the fourth quarter of 2022. In a statement, Novavax wrote that it is awaiting emergency use authorization for its prototype COVID-19 vaccine, noting that clinical data demonstrate it offers immune …

• 

  FOX Business

  

  10 hours ago

  TSA hits pandemic-era record over July 4 weekend

  FOX Business - Julia Musto

  The Transportation Security Administration (TSA) screened more than 9 million travelers between Thursday and Sunday. Through Monday, TSA officers screened about 11.3 million More than 2.49 million individuals headed to airports on Friday – a pandemic-era record. More than 2.1 million people were …

• 

  FOX Business

  

  4 days ago

  Farmers cash in on 'agritourism' amid summer camping season

  FOX Business - Stephen Goin

  At a Christmas tree farm in the heart of Ohio’s Cuyahoga Valley, the start of summer is busier than one might expect. Among the trees, there are dozens of tents and eager campers ready to stay the night. It’s an unusual camping experience Heritage Farms owners George and Carol Haramis have offered …

• 

  FOX Business

  

  4 days ago

  Oxford Biomedica signs new deal to make AstraZeneca COVID shot

  FOX Business - Fox Business

  Britain's Oxford Biomedica said on Friday it had signed a new three-year agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022, but no volumes were defined in an indication of waning demand for the shot. Cell and gene therapy firm Oxford Biomedica said in April that it had …

• 

  FOX Business

  

  5 days ago

  US, Pfizer reach $3.2B COVID vaccine deal

  FOX Business - Julia Musto

  Pfizer and BioNTech SE said Wednesday that they had inked a $3.2 billion agreement with the U.S. government for 105 million doses of their COVID-19 vaccine. The deal includes new versions of the shots, and they would be delivered by the fall, pending a decision by the Food and Drug Administration …